SMS Co., Ltd. (SMSZF)
OTCMKTS · Delayed Price · Currency is USD
8.56
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
SMS Co., Ltd. Revenue
SMS Co., Ltd. had revenue of 13.87B JPY in the quarter ending December 31, 2025, with 6.35% growth. This brings the company's revenue in the last twelve months to 63.41B, up 6.57% year-over-year. In the fiscal year ending March 31, 2025, SMS Co., Ltd. had annual revenue of 60.95B with 12.93% growth.
Revenue (ttm)
63.41B JPY
Revenue Growth
+6.57%
P/S Ratio
2.35
Revenue / Employee
13.49M JPY
Employees
4,701
Market Cap
950.12M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 60.95B | 6.98B | 12.93% |
| Mar 31, 2024 | 53.97B | 8.31B | 18.19% |
| Mar 31, 2023 | 45.67B | 6.77B | 17.40% |
| Mar 31, 2022 | 38.90B | 2.94B | 8.17% |
| Mar 31, 2021 | 35.96B | 820.00M | 2.33% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Vaso Corporation | 89.11M |
| Veri Medtech Holdings | 11.89M |
| Pharma-Bio Serv | 9.00M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |